-
Health benefits and cost-effectiveness of Children’s Oncology Group breast cancer screening guidelines for chest-irradiated Hodgkin Lymphoma survivors
2023
Citation: 41(5):1046-1058
Author(s): Wong FL, Lee JM, Leisenring WM, Neglia JP, Howell RM, Smith SA, Oeffinger KC, Moskowitz CS, Henderson TO, Mertens A, Nathan PC, Yasui Y, Landier W, Armstrong GT, Robison LL, Bhatia S
Journal: J Clin Oncol
-
Inflated expectations: rare-variant association analysis using public controls
2023
Citation: 18(1):e0280951
Author(s): Kim J, Karyadi DM, Hartley SW, Zhu B, Wang M, Wu D, Song L, Armstrong GT, Bhatia S, Robison LL, Yasui Y, Carter B, Sampson JN, Freedman ND, Goldstein AM, Mirabello L, Chanock SJ, Morton LM, Savage SA, Stewart DR
Journal: PLoS One
-
Late health outcomes among survivors of Wilms tumor diagnosed over three decades: a report from the Childhood Cancer Survivor Study
2023
Citation: 41(14):2638-2650
Author(s): Weil BR, Murphy AJ, Liu Q, Howell RM, Smith SA, Weldon CB, Mullen EA, Madenci AL, Leisenring WM, Neglia JP, Turcotte LM, Oeffinger KC, Termuhlen AM, Mostoufi-Moab S, Levine JM, Krull KR, Yasui Y, Robison LL, Armstrong GT, Chow EJ, Armenian SH
Journal: J Clin Oncol
-
Late-onset cognitive impairment and modifiable risk factors in adult childhood cancer survivors
2023
Citation: 6(5):e2316077
Author(s): Phillips NS, Stratton KL, Williams AL, Ahles T, Ness KK, Cohen HJ, Edelstein K, Yasui Y, Oeffinger K, Chow EJ, Howell RM, Robison LL, Armstrong GT, Leisenring WM, Krull KR
Journal: JAMA Netw Open
-
Long-term morbidity and mortality among survivors of neuroblastoma diagnosed during infancy: A report from the Childhood Cancer Survivor Study (CCSS)
2023
Citation: 41(8):1565-1576
Author(s): Friedman DN, Goodman PS, Leisenring WM, Diller LR, Cohn SL, Howell RM, Smith SA, Tonorezos ES, Wolden SL, Neglia JP, Ness KK, Gibson TM, Nathan PC, Weil BR, Robison LL, Oeffinger KC, Armstrong GT, Sklar CA, Henderson TO
Journal: J Clin Oncol
-
Neurocognitive outcomes in adult survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study
2023
Citation: 129(18):2904-2914
Author(s): Hesko C, Liu W, Srivastava D, Brinkman TM, Diller L, Gibson TM, Oeffinger KC, Leisenring WM, Howell R, Armstrong GT, Krull KR, Henderson TO
Journal: Cancer
-
Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcoma.
2023
Citation: 17(4):1238-1250
Author(s): Kadan-Lottick NS, Zheng DJ, Wang M, Bishop MW, Srivastava DK, Ross WL, Rodwin RL, Ness KK, Gibson TM, Spunt SL, Okcu MF, Leisenring WM, Robison LL, Armstrong GT, Krull KR.
Journal: J Cancer Surviv
-
Polygenic risk and chemotherapy-related subsequent malignancies in childhood cancer survivors: a Childhood Cancer Survivor Study and St Jude Lifetime cohort study report
2023
Citation: 41(27):4381-4393
Author(s): Im C, Sharafeldin N, Yuan Y, Wang Z, Sapkota Y, Lu Z, Spector LG, Howell RM, Arnold MA, Hudson MM, Ness KK, Robison LL, Bhatia S, Armstrong GT, Neglia JP, Yasui Y, Turcotte LM
Journal: J. Clin Oncol
-
Primary care utilization and cardiovascular screening in adult survivors of childhood cancer
2023
Citation: 6(12):e2347449
Author(s): Ohlsen TJD, Chen Y, Baldwin L, Hudson MM, Nathan PC, Snyder C, Syrjala KL, Tonorezos ES, Yasui Y, Armstrong GT, Oeffinger KC, Chow EJ
Journal: JAMA Netw Open
-
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: a comparison of two cohort studies
2023
Citation: 12(20):20423-20436
Author(s): Belle FN, Schindera C, Ansari M, Armstrong GT, Beck-Popovic M, Howell R, Leisenring W, Meacham LR, Rossler J, Spycher BD, Tonorezos E, von der Weid NX, Yasui Y, Oeffinger KC, Kuehni CE
Journal: Cancer Med